This optimises mill performanceand enables long-term continuous operation. Low maintenance costsThe SEPAX is designed to be easily service-able. Worn and broken grinding media arenot recycled, which helps to save mainte-nance work on the mill grate plates. Theremoval of nibs from the separator feedreduces the wear on critical separator …
cellular therapeutics, the Sepax cell-separation system was implemen-ted into routine BM processing in 2006. The closed Sepax system provides a reproducible MNC isolation method, and 157 BM samples have been processed with the Sepax device. The results of manual MNC isolation were compared with the Sepax-mediated MNC isolation. Methods
PeriCell C-Pro is Sepax C-Pro protocol software to concentrate peripheral blood stem cells via plasma depletion. Concentrate cells from apheresis product via plasma depletion using PeriCell C-Pro software with Sepax C-Pro instrument. Enables an automatic, reproducible, and user-independent procedure. Initial volume: 100 to 840 mL.
Dilute, concentrate, and wash fresh or frozen cellular products. Dilution C-Pro. CT-49.1 or CT-60.1 or CT-90.1. Dilute and split cellular products into multiple bags for accurate dosing. Improve process efficiency with an automated, simple, and functionally closed system. Maximize cell density and maintain quality by combining high-quality ...
This is likely related to the fact that the automated Sepax significantly shortened the processing time (Sepax: 74 - 175 minutes versus manual method: 180 - 290 minutes). The use of DNAse and MgCl 2 during the Sepax thaw and wash procedure prevents clumping of cells and loss of viability, resulting in improved post-thaw cell recovery.
The Sepax system comprises: • main processing unit • application-speci˜c software protocols • single-use kit The Sepax system is turn-key: no other equipment is required. The Sepax system can be further enhanced for speci˜c applications by addition of: • Coolmix, for automated cryobag mixing and cooling • cryopreparation accessories
The Shimadzu HPLC with Sepax's ZenixTM SEC-300 7.8x300 mm column was used to separate the heavy and light chains. Online Waters Q-TOF mass spectrometer was used to analyze the heavy and light chains. The mobile phase was 0.1% TFA, 0.1% formic acid and 20% acetonitrile. The flow rate was 0.2 mL/min. 5 Pg of reduced MAb 321 was injected …
Biosafe Sepax TM automated system has also been on the rise in the past few years, having different yet similarly viable results as the AXP's system. An interesting publication comparing the Sepax and AXP processing systems was released in July 2013, titled "Qualitative and Quantitative Cell Recovery in Umbilical Cord Blood Processed by …
Newark-based Sepax Technologies Inc. received a positive recommendation for nearly $475,000 in state grants for expansion.. The recommendation came from the Delaware Council on Strategic Finance. The grants are based on achieving job and Since its founding by a University of Delaware alumnus in 2002, Sepax has developed, …
If 600 million cells are recovered from a cord blood unit using open processing method, it can be used to treat a person weighing up to 40 kg. Sepax® can harvest up to 52% more cells which is approximately 312 million more cells, which gives you approximately 912 million cells. This sample can then be used to treat a person weighing up to 60 kg.
SEPAX C-PRO CELL PROCESSING SYSTEM CT-90.1 Sepax C-Pro Kit 2 3 5 6 8 1 9 4 7 The CT-90.1 kit is integral to our Sepax™ C-Pro Cell Processing System. It provides a functionally closed environment and is for single-use only. Key features Part Name Description 1 A-200/F separation chamber Enables centrifugation, capacity of 220 mL
Operating Status Active. Last Funding Type Series D. Also Known As Suzhou Sepax. Legal Name Suzhou Sepax Technologies, Inc. Company Type For Profit. Contact Email info@sepax-tech. Phone Number 302-339-5747. Sepax Technologie is a biotechnology firm that offers ion exchange, hydrophobic interaction, and method …